Klempner, S. J., Gershenhorn, B., Tran, P., Lee, T. K., Erlander, M. G., Gowen, K., . . . Ali, S. M. (2016). BRAF(V600E) Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy. Cancer Discov.
シカゴスタイル引用形Klempner, Samuel J., et al. "BRAF(V600E) Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy." Cancer Discov 2016.
MLA引用形式Klempner, Samuel J., et al. "BRAF(V600E) Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy." Cancer Discov 2016.
警告: この引用は必ずしも正確ではありません.